Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ARMO BioSciences logo — company profile

ARMO BioSciences

Founded 2012 United States Redwood City, United States 1 employees Venture round Total: $167.00M Biotechnology, Health Care +1

General Information

Company Name ARMO BioSciences
Founded Year 2012
Location United States Redwood City, United States
Founders / Decision Makers
Team member
Employees 1
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with ARMO BioSciences. To contact ARMO BioSciences, visit armobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ARMO BioSciences compare?

A PDF of ARMO BioSciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ARMO BioSciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ARMO BioSciences

ARMO BioSciences is a biotechnology and healthcare startup that was founded in 2013. The company received a Venture Round investment on 01 January 2018 from Frazier Healthcare Partners. With a focus on developing novel immuno-oncology therapeutics, ARMO BioSciences has attracted the attention of prominent investors in the healthcare and biotechnology sectors. The company's innovative approach to addressing unmet medical needs in oncology has positioned it as a promising player in the industry. As the company continues to advance its pioneering therapies, it presents an intriguing opportunity for investors seeking exposure to groundbreaking developments in the biotechnology and healthcare space.

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Frazier Healthcare Partners
Frazier Healthcare Partners
01 Jan 2018
Series C $67.00M 10
Kleiner Perkins GV HBM Healthcare Investments
Kleiner Perkins, GV +8
29 Aug 2017
Series C $50.00M 7
Kleiner Perkins DAG Ventures GV
Kleiner Perkins, DAG Ventures +5
10 Feb 2016
Series B $30.00M 4
Kleiner Perkins DAG Ventures OrbiMed
Kleiner Perkins, DAG Ventures +2
28 May 2014
Series A $20.00M 3
Kleiner Perkins DAG Ventures OrbiMed
Kleiner Perkins, DAG Ventures +1
25 Nov 2013
Seed Round Undisclosed 1
Corner Ventures
Corner Ventures
01 Jan 2012

ARMO BioSciences Alternatives & Competitors

View All Alternatives
ARMO BioSciences vs
Imugene Limited
Imugene Limited Australia

Bringing Effective New Treatments And Options To Patients Who Need Them

IPO
26 employees
Biotechnology, Health Care
ARMO BioSciences vs
Surface Oncology Inc.
Surface Oncology Inc. United States

#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021

Post-IPO Equity
14 employees
Biotechnology, Health Care
ARMO BioSciences vs
PDX Pharmaceuticals
PDX Pharmaceuticals United States

Delivery of Next-Gen Combination and Immunotherapies on Nanotechnology Platform.

Series A
9 employees
Biotechnology, Health Care
View all alternatives

FAQ About ARMO BioSciences

ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors. The Company’s lead product candidate, AM0010 (pegilodecakin, PEGylated Interleukin-10)...
ARMO BioSciences was founded in 2012.
ARMO BioSciences is headquartered in Redwood City, United States.
ARMO BioSciences operates in Biotechnology, Health Care and Medical Devices.
ARMO BioSciences has approximately 1 employees.
ARMO BioSciences has completed 6 funding rounds, raising a total of $167.00M. The latest funding stage is Venture round.
Top alternatives and competitors to ARMO BioSciences include Imugene Limited, Surface Oncology Inc., PDX Pharmaceuticals, NBE-Therapeutics AG, Biothera Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ARMO BioSciences and Imugene Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ARMO BioSciences, https://bouncewatch.com/company/armo-biosciences, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout